|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0168 | ED149557 | General Research Use | No | Male | White | 75 | 5 - AREDS AMD Severity Scale Step 4 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_0412 | ED148328 | General Research Use | No | Male | White | 74 | 5 - AREDS AMD Severity Scale Step 3 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0727 | ED149743 | General Research Use | No | Male | White | 71 | 5 - AREDS AMD Severity Scale Step 4 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0815 | ED148038 | General Research Use | No | Female | White | 76 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_0829 | ED150010 | General Research Use | No | Male | White | 75 | 5 - AREDS AMD Severity Scale Step 5 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1038 | ED149031 | General Research Use | No | Female | White | 65 | 5 - AREDS AMD Severity Scale Step 2 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1059 | ED149372 | General Research Use | No | Female | Black or African American | 66 | 5 - AREDS AMD Severity Scale Step 5 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_1100 | ED149009 | General Research Use | No | Female | White | 65 | 5 - AREDS AMD Severity Scale Step 3 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_1150 | ED149263 | General Research Use | No | Female | White | 55 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_1357 | ED150008 | General Research Use | No | Female | White | 51 | 5 - AREDS AMD Severity Scale Step 5 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_1449 | ED148851 | General Research Use | No | Male | White | 75 | 5 - AREDS AMD Severity Scale Step 5 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_1609 | ED149921 | General Research Use | No | Male | White | 85 | 5 - AREDS AMD Severity Scale Step 4 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1798 | ED149966 | General Research Use | No | Female | White | 74 | 5 - AREDS AMD Severity Scale Step 5 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1803 | ED148512 | General Research Use | No | Female | White | 59 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_1814 | ED148699 | General Research Use | No | Male | White | 77 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_1846 | ED148829 | General Research Use | No | Female | White | 60 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_2111 | ED149864 | General Research Use | No | Male | White | 73 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_2348 | ED149162 | General Research Use | No | Male | White | 75 | 5 - AREDS AMD Severity Scale Step 5 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_2874 | ED148371 | General Research Use | No | Female | White | 61 | 5 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2904 | ED148933 | General Research Use | No | Female | White | 62 | 5 - AREDS AMD Severity Scale Step 4 | 6 - AREDS AMD Severity Scale Step 6 |